Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening

被引：15
|
作者：
Rafi, Imran [1 ]
Hill, Melissa [2 ,3 ]
Hayward, Judith [4 ,5 ]
Chitty, Lyn S. [3 ,6 ]
机构：
[1] St Georges Univ London, Primary Care Educ, London, England
[2] UCL Great Ormond St Inst Child Hlth, Genet & Genom Med, London, England
[3] Great Ormond St Hosp Children NHS Fdn Trust, London, England
[4] Yorkshire & Humber GMC, Yorkshire Reg Genet Serv, Genet, Wakefield, England
[5] Hlth Educ England Genom Educ Programme, Birmingham, W Midlands, England
[6] UCL Great Ormond St Inst Child Hlth, Genet & Fetal Med, Genet & Genom Med, London, England
来源：
BRITISH JOURNAL OF GENERAL PRACTICE | 2017年 / 67卷 / 660期
关键词：
MATERNAL BLOOD; ANEUPLOIDIES; DIAGNOSIS;
D O I：
10.3399/bjgp17X691625
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：298 / +
页数：2
相关论文
共 50 条
  • [31] Non-invasive Prenatal Testing Using Fetal DNA
    Giulia Breveglieri
    Elisabetta D’Aversa
    Alessia Finotti
    Monica Borgatti
    Molecular Diagnosis & Therapy, 2019, 23 : 291 - 299
  • [32] Non-invasive Prenatal Testing Using Fetal DNA
    Breveglieri, Giulia
    D'Aversa, Elisabetta
    Finotti, Alessia
    Borgatti, Monica
    MOLECULAR DIAGNOSIS & THERAPY, 2019, 23 (02) : 291 - 299
  • [33] Cell-Free Fetal Deoxyribonucleic Acid (cffDNA) Analysis as a Remarkable Method of Non-Invasive Prenatal Screening
    Raj, Himanshu
    Yelne, Pallavi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [34] Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA
    Mckanna, T.
    Ryan, A.
    Krinshpun, S.
    Kareht, S.
    Marchand, K.
    Grabarits, C.
    Ali, M.
    Mcelheny, A.
    Gardiner, K.
    Lechien, K.
    Hsu, M.
    Saltzman, D.
    Stosic, M.
    Martin, K.
    Benn, P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2019, 53 (01) : 73 - 79
  • [35] Application of fetal cell-free DNA enrichment in non-invasive prenatal screening: experience from a single center in Eastern China
    Lin Ying
    Liang Dong
    Hu Ping
    Li Hang
    Luo Chun-Yu
    Xu Zheng-Feng
    中华医学杂志英文版, 2021, 134 (01) : 104 - 106
  • [36] Application of fetal cell-free DNA enrichment in non-invasive prenatal screening: experience from a single center in Eastern China
    Lin, Ying
    Liang, Dong
    Hu, Ping
    Li, Hang
    Luo, Chun-Yu
    Xu, Zheng-Feng
    CHINESE MEDICAL JOURNAL, 2021, 134 (01) : 104 - 106
  • [37] Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing
    Juozas Gordevičius
    Milda Narmontė
    Povilas Gibas
    Kotryna Kvederavičiūtė
    Vita Tomkutė
    Priit Paluoja
    Kaarel Krjutškov
    Andres Salumets
    Edita Kriukienė
    Clinical Epigenetics, 2020, 12
  • [38] Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing
    Gordevicius, Juozas
    Narmonte, Milda
    Gibas, Povilas
    Kvederaviciute, Kotryna
    Tomkute, Vita
    Paluoja, Priit
    Krjutskov, Kaarel
    Salumets, Andres
    Kriukiene, Edita
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [39] Cell-free fetal DNA based non-invasive prenatal testing: a systematic review and meta-analysis of diagnostic accuracy
    Mackie, F. L.
    Morris, R. K.
    Hemming, K.
    Allen, S.
    Kilby, M. D.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 : 2 - 3
  • [40] Budget impact of incorporating non-invasive prenatal testing in prenatal screening for Down syndrome in Turkey
    Okem, Zeynep Guldem
    Orgul, Gokcen
    Kasnakoglu, Berna Tari
    Cakar, Mehmet
    Beksac, Mehmet Sinan
    HEALTH POLICY AND TECHNOLOGY, 2019, 8 (04) : 402 - 407
12345